We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Idera Pharmaceuticals Inc | NASDAQ:IDRA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.425 | 0.432 | 0.48 | 0 | 01:00:00 |
1. Name and Address of Reporting Person * Pillar Invest Corp | 2. Issuer Name and Ticker or Trading Symbol IDERA PHARMACEUTICALS, INC. [ IDRA ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director __X__ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
3. Date of Earliest Transaction
(MM/DD/YYYY)
| ||
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
1.Title of Security (Instr. 3) | 2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code (Instr. 8) |
4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 4/17/2020 | J(1) | 46304 | D | $0.00 | 5427697 | I | By Pillar Partners Foundation, L.P. See Footnotes (1)(3) | ||
Common Stock | 4/17/2020 | J(1) | 103891 | D | $0.00 | 1288368 | I | By Pillar Pharmaceuticals 6, L.P. See Footnotes (2)(3) | ||
Common Stock | 21100 | I | By Pillar Pharmaceuticals I, L.P. See Footnote (3) | |||||||
Common Stock | 20820 | I | By Pillar Pharmaceuticals II, L.P. See Footnote (3) | |||||||
Common Stock | 29998 | I | By Pillar Pharmaceuticals III, L.P. See Footnote (3) | |||||||
Common Stock | 1000 | I | By Pillar Pharmaceuticals IV, L.P. See Footnote (3) | |||||||
Common Stock | 25000 | I | By Pillar Pharmaceuticals V, L.P. See Footnote (3) | |||||||
Common Stock | 6724 | I | By Youssef El Zein See Footnote (3) | |||||||
Common Stock | 190117 | I | By Abude Umari See Footnotes (3)(4) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
1. Title of Derivate Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any | 4. Trans. Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Reporting Owners | |||||
Reporting Owner Name / Address | |||||
Director | 10% Owner | Officer | Other | ||
Pillar Invest Corp PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT, M8 2020-3313 | X | ||||
Pillar Partners Foundation, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT, M8 2020-3313 | X | ||||
Pillar Pharmaceuticals 6, L.P. PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT, M8 2020-3313 | X | ||||
Umari Abude PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT, M8 2020-3313 | X | ||||
ZEIN YOUSSEF EL PILLAR INVEST OFFSHORE SAL STARCO CTR, BLOC B, 3RD FLOOR, OMAR DAOUK STREET BEIRUT, M8 2020-3313 | X |
Signatures | ||
Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person | 9/4/2020 | |
**Signature of Reporting Person | Date | |
Pillar Partners Foundation, L.P., /s/ Youssef El Zein, Authorized Person | 9/4/2020 | |
**Signature of Reporting Person | Date | |
Pillar Pharmaceuticals, 6, L.P., /s/ Youssef El Zein, Authorized Person | 9/4/2020 | |
**Signature of Reporting Person | Date | |
/s/ Abude Umari | 9/4/2020 | |
**Signature of Reporting Person | Date | |
/s/ Youssef El Zein | 9/4/2020 | |
**Signature of Reporting Person | Date |
1 Year Idera Pharmaceuticals Chart |
1 Month Idera Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions